TCRX icon

TScan Therapeutics
TCRX

Overview Fund Activity

28 hedge funds and large institutions have $14.8M invested in TScan Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NW
1
NewEdge Wealth
Pennsylvania
$142K
2
NM
2
Newtyn Management
New York
$375K
3
Millennium Management
3
Millennium Management
New York
$31K
4
Northern Trust
4
Northern Trust
Illinois
$17.4K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$16K

Top Sellers

1
WP
1
Woodline Partners
California
$0
2
MAM
2
Marquette Asset Management
Minnesota
$0
3
TCM
3
Tang Capital Management
California
$798K
4
Morgan Stanley
4
Morgan Stanley
New York
$65.4K
5
UBS Group
5
UBS Group
Switzerland
$1.55K
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
26
Atlas Capital Advisors
Wyoming
$1.39K 896 – –
Bank of America
27
Bank of America
North Carolina
$362 234 +234 New
Wells Fargo
28
Wells Fargo
California
$113 73 +1 +1%
WP
29
Woodline Partners
California
– – -66,601 Closed
MAM
30
Marquette Asset Management
Minnesota
– – -28,895 Closed
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
– – -184 Closed
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
1
2